摘要
《中国心血管健康与疾病报告2021》指出我国心血管病患病率处于持续上升阶段,每5例死亡中就有2例死于心血管病。而心力衰竭是各种心血管疾病的终末阶段,严重影响了人类的生存质量。其中射血分数保留的心力衰竭(Heart failure with preserved ejection fraction, HFpEF)的占比越来越大。目前关于HFpEF的病理生理机制不明确,诊断及治疗暂无较大突破,但近几年提出H2FPEF评分有助于该疾病的诊断,甚至有研究表明可以预测心血管不良事件的发生。现将H2FPEF评分近几年的研究作一阐述。
China Cardiovascular Health and Disease Report 2021 pointed out that the prevalence of cardio-vascular disease in my country is on the rise, and 2 out of every 5 deaths are due to cardiovascular disease. Heart failure is the terminal stage of various cardiovascular diseases, which seriously af-fects the quality of human life. The proportion of heart failure with preserved ejection fraction (HFpEF) is increasing. At present, the pathophysiological mechanism of HFpEF is unclear, and there has been no major breakthrough in diagnosis and treatment. However, in recent years, it has been proposed that the H2FPEF score is helpful for the diagnosis of the disease, and some studies have even shown that it can predict the occurrence of adverse cardiovascular events. Now, the research on H2FPEF score in recent years will be described.
出处
《临床医学进展》
2022年第11期9871-9877,共7页
Advances in Clinical Medicine
